Does OLAPARIB Cause Infection? 84 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Infection have been filed in association with OLAPARIB (Lynparza). This represents 0.5% of all adverse event reports for OLAPARIB.
84
Reports of Infection with OLAPARIB
0.5%
of all OLAPARIB reports
14
Deaths
46
Hospitalizations
How Dangerous Is Infection From OLAPARIB?
Of the 84 reports, 14 (16.7%) resulted in death, 46 (54.8%) required hospitalization, and 5 (6.0%) were considered life-threatening.
Is Infection Listed in the Official Label?
Yes, Infection is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Infection?
ADALIMUMAB (11,552)
METHOTREXATE (10,406)
ETANERCEPT (10,379)
RITUXIMAB (9,575)
ABATACEPT (7,821)
TOCILIZUMAB (7,349)
PREDNISONE (6,334)
TOFACITINIB (6,332)
INFLIXIMAB (6,122)
CERTOLIZUMAB PEGOL (5,954)
Which OLAPARIB Alternatives Have Lower Infection Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL